{
    "organizations": [],
    "uuid": "65cdb9da3e36c9d0f5cecc88ce3aac03b470abf8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunocellular-therapeutics-receiv/brief-immunocellular-therapeutics-receives-audit-opinion-with-going-concern-explanation-idUSFWN1R80CL",
    "ord_in_thread": 0,
    "title": "BRIEF-ImmunoCellular Therapeutics Receives Audit Opinion With Going Concern Explanation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Immunocellular Therapeutics Ltd :\n* IMMUNOCELLULAR THERAPEUTICS RECEIVES AUDIT OPINION WITH GOING CONCERN EXPLANATION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-03-26T18:35:00.000+03:00",
    "crawled": "2018-03-27T12:07:29.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "immunocellular",
        "therapeutic",
        "ltd",
        "immunocellular",
        "therapeutic",
        "receives",
        "audit",
        "opinion",
        "going",
        "concern",
        "explanation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}